further reading without the trolls

some balanced reports and key documents related to isoneas progress. the first one is the clinical trial details. these are well worth reading and offer a far greater and balanced insight into isn's strengths and weaknesses. Does show (be reports positive or negative) that Thomas is getting out and about and getting coverage for the company. Take up will be crucial factor, but no one can say management is not keen to hit milestones. Put the trolls on ignore and as always dyor


http://www.clinicaltrials.gov/ct2/show/NCT01556958?term=isonea&rank=1 The study of 95 children up to 12 years old started this month.

http://www.fiercemobilehealthcare.com/story/isonea-debuts-asthma-app-platform/2012-04-02

http://www.bizreview.com.au/p/technology/don_hold_your_breath_for_this_app_G2p8ywDfumc9ugTrpZstAK

http://mobihealthnews.com/16797/isonea-begins-recruiting-for-pediatric-asthma-trial/

http://www.mhimss.org/news/isonea-looks-turn-smartphone-breathing-monitor

http://www.highlighthealth.org/medical-device-technology/isonea-to-build-mobile-asthma-management-apps-on-qualcomms-platform/

http://www.brrmedia.com/event/95471/mr-michael-thomas-ceo

http://www.trademarkia.com/company-isonea-limited-3801209-page-1-2